Author

Hassan Mohammadi

Institutions: Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences

Observed institutions: Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences

OpenAlex ID: A5140601719

Design, synthesis, and in vitro/in vivo evaluation of novel diphenyl-1,2,4-triazine-3-yl-thioacetamide-chalcone hybrids as potent α-glucosidase inhibitors targeting type 2 diabetes

2026 · Elika Salehi Ghalehsefid, Mohammad Halimi, et al. · European Journal of Medicinal Chemistry

Design and synthesis of new donepezil-based chalcones as multi-target-directed ligands against Alzheimer's disease: biological evaluation, molecular dynamics, and zebrafish model studies

2026 · Babak Geraiely, Ebrahim Kianmehr, et al. · RSC Advances

Targeted Cholinesterase Inhibition by Novel Oxoisoindoline Derivatives with Potential Activity Against BACE1 and Serotonin Receptor

2026 · Navid Dastyafteh, Milad Noori, et al. · RSC Medicinal Chemistry

Novel diazene-tri(phenoxy-1,2,3-triazole-acetamide) derivatives as potent α-glucosidase inhibitors: synthesis, biological evaluation, and in silico studies

2026 · Shahab Kermaninia, Mohammad Hosein Sayahi, et al. · RSC Advances

Works count: 4

Citation count:

H-index:

I10-index: